MAPT and Alzheimer disease: Thus, these compounds indicate putative anti-AD properties by reducing acetylcholine breakdown, which is diminished in AD, as well as antioxidant properties potentially reducing amyloid b (Ab) and tau tangles, which are caused by oxidative damage [114].